Prevalence and Risk Factors of Microalbuminuria in Type 2 Diabetic Patients in a Diabetic Clinic of Ardabil-Iran

M Iranparvar Alamdari; N Aminisani; B Bashardoost; SM Shamshirgaran; M Khodamoradzadeh; M Shokrabadi; B Olomi

International Journal of Endocrinology and Metabolism

Research Institute for Endocrine Sciences

Current Issue All Issues In Press Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Prevalence and Risk Factors of Microalbuminuria in Type 2 Diabetic Patients in a Diabetic Clinic of Ardabil-Iran

Author(s):

M Iranparvar Alamdari^1,*,

N Aminisani²,

B Bashardoost²,

SM Shamshirgaran²,

M Khodamoradzadeh²,

M Shokrabadi²,

B Olomi²

1Ardabil University of Medical Sciences and Health Services, M.Iranparvar@arums.ac.ir, IR.Iran

2Ardabil University of Medical Sciences and Health Services, IR.Iran

International Journal of Endocrinology and Metabolism:Vol. 4, issue 1; 8-12

Article type:Research Article

Received:Apr 01, 2005

Accepted:Dec 01, 2005

How to Cite:M Iranparvar AlamdariN AminisaniB BashardoostSM ShamshirgaranM KhodamoradzadehM ShokrabadiB Olomiet al.Prevalence and Risk Factors of Microalbuminuria in Type 2 Diabetic Patients in a Diabetic Clinic of Ardabil-Iran.Int J Endocrinol Metab.4(1):8-12.

Abstract

This study was carried out to determine the prevalence of microalbuminuria in type 2 diabetes and their relationship with risk factors. Materials & Methods: The study was performed at the outpatient diabetes clinic of Ardabil. We selected patients who had no evidence of proteinuria in urinalysis and without abnormal serum blood urea nitrogen (BUN) and creatinine. The patients were directed to provide timed 24 hour urine samples for assessment of urinary albumin twice in a period of 2-3 months. In the course of processing case histories the factors considered were duration of diabetes, hypertension history, smoking habits and number of visits during the previous year. Laboratory investigations included FBS, HbA1c, Tg, Cholesterol (Total, HDL, LDL), BUN and creatinine. Results: The prevalence of microalbuminuria (AER 31-299 mg/24 hr) was 30.5%. Significant differences were found with regard to duration of diabetes (p<0.01), hypertension (p<0.0001) and smoking habits (p<0.05) and the mean value of fasting plasma glucose (171±71 v.s 138±48, p=0.01) and triglyceride, (247±142 v.s 201±105, p=0.05). HbA1c levels (7.3±1.3 v.s 6.5±1.3, p=0.01) were significantly high in patients with microal- buminuria as compared to patients with nor- moalbuminuria, serum cholesterol; HDL and LDL showed no significant difference. Conclusion: Microalbuminuria was a major problem in our patients. Hypertension, smoking, poor glycemic control, duration of diabetes and serum levels of triglyceride were risk factors for development of microalbuminuria.

Keywords

Type 2 Diabetes Mellitus

Microalbuminuria

Risk Factor

Full Text

Full text is available in PDF

comments